Governor Cuomo Announces Groundbreaking Clinical Trial of Cuban-Developed Lung Cancer Treatment

Earlier today, Governor Andrew M. Cuomo announced that the Buffalo-based Roswell Park Cancer Institute will launch a groundbreaking clinical trial of CIMAvax-EGF – a Cuban-developed lung cancer treatment. The announcement comes on the heels of Governor Cuomo’s landmark trade mission to Cuba last year, where he facilitated and secured the first-in-the-nation partnership between Roswell Park and the Havana-based Center of Molecular Immunology. The joint venture makes Roswell Park the first medical institution to receive FDA permission to sponsor testing of a Cuban medical therapy in the United States. The new study – which is the culmination of formal agreements between state, federal and Cuban officials during the historic 2015 trade mission – is expected to begin in November. More information is available here. 

The letter from Cuban Ambassador José Ramón Cabañas Rodríguez congratulating Governor Cuomo on the historic partnership is available here.

A video detailing cancer treatment’s impacts is available here.

Source: Press Office, Governor Andrew M. Cuomo